SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-20-020220
Filing Date
2020-02-13
Accepted
2020-02-13 16:27:27
Documents
1
Group Members
DAN MACKWILMOT B. HARKEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm207751d16_sc13ga.htm SC 13G/A 49139
  Complete submission text file 0001104659-20-020220.txt   50725
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Subject) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-88949 | Film No.: 20611028
SIC: 2834 Pharmaceutical Preparations

Mailing Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840
Business Address 130 MAIN ST. 2ND FLOOR NEW CANAAN CT 06840 203-404-1172
Nantahala Capital Management, LLC (Filed by) CIK: 0001472322 (see all company filings)

IRS No.: 201151760 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A